These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29695655)

  • 21. A Pilot Study of Femoropopliteal Artery Revascularisation with a Low Dose Paclitaxel Coated Balloon: Is Predilatation Necessary?
    Schroeder H; Meyer DR; Lux B; Ruecker F; Martorana M; Miller LE; Duda S
    Eur J Vasc Endovasc Surg; 2017 Sep; 54(3):348-355. PubMed ID: 28778456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of femoro-popliteal lesions with scoring and drug-coated balloon angioplasty: 12-month results of the DCB-Trak registry.
    Baumhäkel M; Chkhetia S; Kindermann M
    Diagn Interv Radiol; 2018; 24(3):153-157. PubMed ID: 29770768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-Year Clinical Outcomes of the CONSEQUENT Trial: Can Femoropopliteal Lesions be Treated with Sustainable Clinical Results that are Economically Sound?
    Albrecht T; Waliszewski M; Roca C; Redlich U; Tautenhahn J; Pech M; Halloul Z; Gögebakan Ö; Meyer DR; Gemeinhardt I; Zeller T; Müller-Hülsbeck S; Ott I; Tepe G
    Cardiovasc Intervent Radiol; 2018 Jul; 41(7):1008-1014. PubMed ID: 29589098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized controlled trial of orchid drug-coated balloon versus standard percutaneous transluminal angioplasty for treatment of femoropopliteal artery in-stent restenosis.
    Liao CJ; Song SH; Li T; Zhang Y; Zhang WD
    Int Angiol; 2019 Oct; 38(5):365-371. PubMed ID: 31566320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraluminal vs Subintimal Drug-Coated Balloon Angioplasty for the Treatment of Femoropopliteal Chronic Total Occlusions.
    Toyoshima T; Takahara M; Iida O; Tomoi Y; Kawasaki D; Tanaka A; Yamauchi Y; Tobita K; Kozuki A; Fujihara M; Higuchi Y; Soga Y;
    JACC Cardiovasc Interv; 2024 Mar; 17(5):608-618. PubMed ID: 38479962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reewarm™ PTX drug-coated balloon in the treatment of femoropopliteal artery disease: A multi-center, randomized controlled trial in China.
    Ye W; Zhang X; Dai X; Huang X; Liu Z; Jiang M; Liu C
    Int J Cardiol; 2021 Mar; 326():164-169. PubMed ID: 33127414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon.
    Schneider PA; Laird JR; Doros G; Gao Q; Ansel G; Brodmann M; Micari A; Shishehbor MH; Tepe G; Zeller T
    J Am Coll Cardiol; 2019 May; 73(20):2550-2563. PubMed ID: 30690141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total IN.PACT All-Subjects One-Year Analysis and Standard vs Broader Implications.
    Kobe DS; Jaff MR; Zeller T; Schneider PA; Shishehbor MH
    J Invasive Cardiol; 2020 Jul; 32(7):243-248. PubMed ID: 32610266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-Coated Balloon Versus Plain Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Giacoppo D; Cassese S; Harada Y; Colleran R; Michel J; Fusaro M; Kastrati A; Byrne RA
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1731-42. PubMed ID: 27539695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
    Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
    Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes and Comparative Analysis of the Initial Results of Standard Balloon Angioplasty Versus Drug-Coated Balloons Alone Versus in Association With Laser-Excimer Atherectomy in the Treatment of Femoropopliteal Artery In-Stent Restenosis (INTACT).
    Ducasse E; Sapoval M; Brunet J; Commeau P; Goueffic Y; Sabatier J; Steinmetz E; Lermusiaux P; Rosset E; Caradu C
    J Endovasc Ther; 2024 Apr; ():15266028241248333. PubMed ID: 38659343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-Coated vs Uncoated Percutaneous Transluminal Angioplasty in Infrapopliteal Arteries: Six-Month Results of the Lutonix BTK Trial.
    Mustapha JA; Brodmann M; Geraghty PJ; Saab F; Settlage RA; Jaff MR;
    J Invasive Cardiol; 2019 Aug; 31(8):205-211. PubMed ID: 31368893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective analysis on diameters of drug-coated balloons and predilatation balloons in infra-inguinal endovascular treatment (RABBIT study).
    Iwata Y; Takahara M; Tobita K; Hayakawa N; Mori S; Horie K; Nakama T; Suzuki K; Fukuzawa S
    Cardiovasc Interv Ther; 2024 Jul; 39(3):293-301. PubMed ID: 38632168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between paclitaxel-coated balloon and standard uncoated balloon in the treatment of femoropopliteal long lesions in diabetics.
    Du X; Wang F; Wu DM; Zhang MH; Jia X; Zhang JW; Zhuang BX; Zhao Y; Guo PF; Bi W; Fu WG; Guo W; Wang SM
    Medicine (Baltimore); 2019 Mar; 98(13):e14840. PubMed ID: 30921183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative 12-Month Outcomes of Drug-Coated Balloon Versus Non-Drug-Coated Balloon Revascularization Strategy in Chronic Limb-Threatening Ischemia: Results From the XLPAD Registry.
    Giannopoulos S; Jeon-Slaughter H; Kahlon RS; Tejani I; Baskar A; Banerjee S; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Oct; 21(10):1276-1284. PubMed ID: 32249170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Outcomes of Repetition of Drug-Coated Balloon for Femoropopliteal Restenosis After Drug-Coated Balloon Treatment.
    Jang SJ; Chou HH; Juang JJ; Hsieh CA; Duan DM; Huang HL; Ko YL
    Circ J; 2017 Jun; 81(7):993-998. PubMed ID: 28344208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mid- and long-term outcomes and prognostic factors of drug-coated balloon angioplasty for treatment of femoropopliteal long lesions].
    Cao ZJ; Zhang T; Zhao KQ; Zhao JL; Yu XH; Li YW; Wu WW
    Zhonghua Wai Ke Za Zhi; 2022 Jan; 60(1):57-62. PubMed ID: 34954948
    [No Abstract]   [Full Text] [Related]  

  • 39. A Patient-Level, Pooled Analysis of Mortality Rates With the Passeo-18 Lux Paclitaxel Drug-Coated Balloon in Peripheral Arterial Disease.
    Forrestal BJ; Zhang C; Case BC; Yerasi C; Craig PE; Torguson R; Bernardo NL; Waksman R
    Cardiovasc Revasc Med; 2021 Dec; 33():49-54. PubMed ID: 34090794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.
    Rosenfield K; Jaff MR; White CJ; Rocha-Singh K; Mena-Hurtado C; Metzger DC; Brodmann M; Pilger E; Zeller T; Krishnan P; Gammon R; Müller-Hülsbeck S; Nehler MR; Benenati JF; Scheinert D;
    N Engl J Med; 2015 Jul; 373(2):145-53. PubMed ID: 26106946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.